MicroRNA-141 enhances anoikis resistance in metastatic progression of ovarian cancer through targeting KLF12/Sp1/survivin axis-Reference-Cited by-同舟云学术

MicroRNA-141 enhances anoikis resistance in metastatic progression of ovarian cancer through targeting KLF12/Sp1/survivin axis

Published:2017-01-17 Issue:1 Volume:16 Page:
ISSN:1476-4598
Container-title:Molecular Cancer
language:en
Short-container-title:Mol Cancer

Author:

Mak Celia S. L.,Yung Mingo M. H.,Hui Lynn M. N.,Leung Leanne L.,Liang Rui,Chen Kangmei,Liu Stephanie S.,Qin Yiming,Leung Thomas H. Y.,Lee Kai-Fai,Chan Karen K. L.,Ngan Hextan Y. S.,Chan David W.

Funder

Hong Kong Research Grants Council General Research Fund

HKU Seed Funding Programme for Basic Research

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Molecular Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12943-017-0582-2.pdf

Reference65 articles.

1. Pereira A, Magrina JF, Magtibay PM, Perez-Medina T, Fernandez A, Peregrin I. The impact of peritoneal metastases in epithelial ovarian cancer with positive nodes. Int J Gynecol Cancer. 2011;21(8):1375–9.

2. Ursini-Siegel J, Siegel PM. The influence of the pre-metastatic niche on breast cancer metastasis. Cancer Lett. 2015;380(1):281–8.

3. Fidler IJ. The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. Nat Rev Cancer. 2003;3(6):453–8.

4. Simpson CD, Anyiwe K, Schimmer AD. Anoikis resistance and tumor metastasis. Cancer Lett. 2008;272(2):177–85.

5. Lu Z, Wang J, Wientjes MG, Au JL. Intraperitoneal therapy for peritoneal cancer. Future Oncol. 2010;6(10):1625–41.

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. KLF12 interacts with TRIM27 to affect cisplatin resistance and cancer metastasis in esophageal squamous cell carcinoma by regulating L1CAM expression;Drug Resistance Updates;2024-09

2. Prognostic value of anoikis-related genes revealed using multi-omics analysis and machine learning based on lower-grade glioma features and tumor immune microenvironment;Heliyon;2024-09

3. Targeting anoikis resistance as a strategy for cancer therapy;Drug Resistance Updates;2024-07

4. Identification and validation of a novel anoikis‐related prognostic model for prostate cancer;Molecular Genetics & Genomic Medicine;2024-04

5. Correlation analysis of fatty acid metabolism-related genes and the prognosis of ovarian cancer;2024-02-28